INS and type 1 diabetes mellitus: Considering the etiology of T1D, cell-based therapy and experimental models aim to simulate the native environment as well as seek strategies to advance the insulin secretion, lower cell/transplant number, find alternative insulin-secreting cell sources and provide companion cells to stimulate the viability and the vascularization.